Home › Ipsen Announces A Step Forward In The Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S.
 

Keywords :   


Ipsen Announces A Step Forward In The Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S.

2014-05-16 10:04:38| foodingredientsonline Home Page

Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), today announced that a supply of Increlex (mecasermin [rDNA origin] injection) will be available in the U.S. starting June 2, 2014

Tags: the us step forward

Category:Food and Related Products

Latest from this category

All news
»
29.06Tropical Storm Beryl Public Advisory Number 3A
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Graphics
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
29.06Weekly Recap: PPG, Hempel, Beckers Group Top This Weeks Stories
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 3
More »